Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
Authors
Keywords
Surgical and invasive medical procedures, Stromal cells, Cell staining, Prognosis, Cancer treatment, Fibroblasts, Immunohistochemistry techniques, Metastasis
Journal
PLoS One
Volume 11, Issue 3, Pages e0152523
Publisher
Public Library of Science (PLoS)
Online
2016-03-30
DOI
10.1371/journal.pone.0152523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression
- (2015) Austin R. Cannon et al. Cytoskeleton
- Neoadjuvant Gemcitabine-based Accelerated Hyperfractionation Chemoradiotherapy for Patients with Borderline Resectable Pancreatic Adenocarcinoma
- (2014) Y. Takeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton
- (2014) Pernilla von Nandelstadh et al. MOLECULAR BIOLOGY OF THE CELL
- Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information
- (2014) Mireia Berdiel-Acer et al. Molecular Oncology
- Cancer-associated fibroblasts: Recent developments and emerging challenges
- (2014) Arne Östman SEMINARS IN CANCER BIOLOGY
- Prognostic relevance of cancer-associated fibroblasts in human cancer
- (2014) Janna Paulsson et al. SEMINARS IN CANCER BIOLOGY
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
- (2013) Fuyuhiko Motoi et al. ANNALS OF SURGICAL ONCOLOGY
- Tumour–stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
- (2013) V. Heinemann et al. CANCER TREATMENT REVIEWS
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
- (2013) Fiorenza Lotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pan
- (2013) Sohei Satoi et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Podoplanin, α-Smooth Muscle Actin or S100A4 Expressing Cancer-Associated Fibroblasts Are Associated with Different Prognosis in Colorectal Cancers
- (2013) Song-Yi Choi et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas
- (2013) Koji Shindo et al. Molecular Cancer
- Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts
- (2013) S M Goicoechea et al. ONCOGENE
- Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts
- (2012) L J A C Hawinkels et al. ONCOGENE
- Arousal of Cancer-Associated Stroma: Overexpression of Palladin Activates Fibroblasts to Promote Tumor Invasion
- (2012) Teresa A. Brentnall et al. PLoS One
- Pancreatic cancer: Translational research aspects and clinical implications
- (2012) Daniel Ansari WORLD JOURNAL OF GASTROENTEROLOGY
- Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
- (2011) Qing Zhao et al. Annals of Diagnostic Pathology
- Assessing Treatment Effect in Pancreatic Cancer
- (2011) Douglas J Hartman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma
- (2011) Deyali Chatterjee et al. CANCER
- Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma
- (2011) Vivekanand Gupta et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors
- (2010) Silvia M. Goicoechea et al. PLoS One
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
- (2008) Mert Erkan et al. Clinical Gastroenterology and Hepatology
- Effect of Neoadjuvant Therapy on Local Recurrence after Resection of Pancreatic Adenocarcinoma
- (2008) Sarah E. Greer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More